Brilinta/aspirin combo could be the first US-approved dual antiplatelet therapy to cut risk of second stroke

Joint commitment led by the Royal Society of Chemistry, which has created a framework to reduce bias and […]

The drug hit primary and secondary goals of the Phase III FIDELIO-DKD renal outcomes study

A research team from Leibniz IPHT in Jena has built electrodes with outstanding optical and electronic properties from […]

A milestone in hearing research: Researchers at the University Medical Center Göttingen and the University of Freiburg combine […]

Updated Date: Thu, 02 Jul 2020 00:00:00 EDT

Updated Date: Thu, 02 Jul 2020 00:00:00 EDT

Updated Date: Thu, 02 Jul 2020 00:00:00 EDT

Updated Date: Thu, 02 Jul 2020 00:00:00 EDT

Updated Date: Thu, 02 Jul 2020 00:00:00 EDT